Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis (SURPASS):
ClinicalTrials.gov Description
===
Corporate press release
===
ClinicalTrials.gov Description
===
Corporate press release
===
News about our knowledge of the brain and behavior
from Anthony Risser, Ph.D.
Comments